Comparison 18. Hyalgan versus Hylan G‐F 20.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Safety: number of patients with local reaction (acute inflammation and pain) | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only |